why choose us

First received: August 01, 2023

Clinical Trial: Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Opiate Withdrawal Syndrome

Study Type: INTERVENTIONAL


Official Title: Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal

Brief Summary: A placebo-controlled trial in which male and female outpatients with an opioid use disorder who express interest in extended-release injectable naltrexone (XR-NTX) are randomized 1:1 to lofexidine/pregabalin or lofexidine/pregabalin placebo for withdrawal management and offered XR-NTX if after completing withdrawal.

Read more